Drug Licence Cannot Be Suspended Concurrently with Show Cause Notice: Karnataka High Court
- Statutes
- Drugs and Cosmetics Act, 1940 — s.35
- Source
- LiveLaw
The Karnataka High Court ruled that a drug licence cannot be suspended simultaneously with the issuance of a show cause notice under Section 35 of the Drugs and Cosmetics Act, 1940. The court emphasized that suspension must follow due process, including considering the licensee's reply, and cannot be a pre-emptive measure.
Ratio Decidendi · Legal Principle Established
The ratio decidendi is that the power to suspend a drug licence under Section 35 of the Drugs and Cosmetics Act, 1940, can only be exercised after affording the licensee a reasonable opportunity to show cause and considering their reply. Concurrent suspension with a show cause notice violates principles of natural justice and statutory procedure.
Practice & Procedural Impact for Advocates
Advocates should challenge any pre-emptive suspension of drug licences issued concurrently with a show cause notice, arguing a violation of natural justice. Litigants facing such action should immediately respond to the show cause notice while simultaneously seeking judicial intervention against the premature suspension.
Key Legal Takeaways
- 1Suspension of a drug licence must follow, not precede, the show cause process.
- 2Issuing a show cause notice and immediate suspension simultaneously is procedurally improper.
- 3The Drugs and Cosmetics Act, 1940, mandates considering the licensee's reply before suspension.
- 4Principles of natural justice require a fair hearing before punitive action like suspension.
The Legal Issue
The core legal issue addressed by the Karnataka High Court was whether a drug licence can be suspended concurrently with the issuance of a show cause notice under Section 35 of the Drugs and Cosmetics Act, 1940. The petitioners challenged the practice of authorities suspending their drug licences at the very moment they were issued a show cause notice, arguing that such an action violated principles of natural justice and the statutory scheme.
Court's Reasoning
The Karnataka High Court held that the suspension of a drug licence cannot be effected simultaneously with the issuance of a show cause notice. The court emphasized that Section 35 of the Drugs and Cosmetics Act, 1940, contemplates a procedure where a licensee is first given an opportunity to show cause against a proposed action. Only after considering the reply furnished by the licensee can the competent authority decide whether to suspend or cancel the licence. The court reasoned that a pre-emptive suspension, without evaluating the licensee's response, amounts to a violation of the principles of natural justice, as it deprives the licensee of a fair hearing before a punitive measure is taken. The court clarified that the power to suspend is not an automatic consequence of issuing a show cause notice but a discretionary power to be exercised judiciously after due process.
Why It Matters
This decision is significant for all drug manufacturers, distributors, and retailers in India. It reinforces the importance of due process and natural justice in administrative actions, particularly when they involve the suspension of a licence crucial for business operations. For advocates, it provides a strong legal basis to challenge any arbitrary or pre-emptive suspension orders issued by drug control authorities. Litigants can now confidently argue that their licence cannot be suspended until their response to a show cause notice has been duly considered, ensuring that they are afforded a fair opportunity to present their case before any adverse action is taken. This ruling safeguards against potential misuse of power by regulatory bodies and upholds the procedural fairness enshrined in Indian administrative law.